APOB and myeloid sarcoma: Regarding ratios, IDL-TG/IDL-apoB was significantly higher and IDL-PL/IDL-apoB was significantly lower in MS patients compared with HVs, whereas IDL-C/IDL-apoB and IDL-FC/IDL-apoB were similar in both groups (Table S3).